Free release
230299-17-9 (3aR,3'aR,4R,4'R,6R,6'R,7aS,7'aS)-Dodecahydro-3a,3'a,5,5,5',5'-hexamethyl-2,2'-bi-4,6-me

230299-17-9 (3aR,3'aR,4R,4'R,6R,6'R,7aS,7'aS)-Dodecahydro-3a,3'a,5,5,5',5'-hexamethyl-2,2'-bi-4,6-me

CAS No. :230299-17-9MDL No. :MFCD02683577Formula :C20H32B2O4Boiling Point :-Linear Structure Formula :-InChI Key :-M.W :

Sales:Service@apichina.com
CAS No. :230299-17-9 Brand :Qitai
Formula :C20H32B2O4 M.W :358.09

Introduction

CAS No. :230299-17-9 MDL No. :MFCD02683577
Formula : C20H32B2O4 Boiling Point : -
Linear Structure Formula :- InChI Key :-
M.W : 358.09 Pubchem ID :-
Synonyms :

Physicochemical Properties

Num. heavy atoms : 26
Num. arom. heavy atoms : 0
Fraction Csp3 : 1.0
Num. rotatable bonds : 1
Num. H-bond acceptors : 4.0
Num. H-bond donors : 0.0
Molar Refractivity : 103.09
TPSA : 36.92 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : Yes
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.39 cm/s

Lipophilicity

Log Po/w (iLOGP) : 0.0
Log Po/w (XLOGP3) : 4.36
Log Po/w (WLOGP) : 3.52
Log Po/w (MLOGP) : 2.34
Log Po/w (SILICOS-IT) : 0.81
Consensus Log Po/w : 2.21

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -4.74
Solubility : 0.0065 mg/ml ; 0.0000182 mol/l
Class : Moderately soluble
Log S (Ali) : -4.85
Solubility : 0.00505 mg/ml ; 0.0000141 mol/l
Class : Moderately soluble
Log S (SILICOS-IT) : -3.64
Solubility : 0.0826 mg/ml ; 0.000231 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 2.0
Synthetic accessibility : 6.25
Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram: